Trump Team Weighs Pulling Funds for Moderna Bird Flu Vaccine
US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to Moderna Inc., people familiar with the matter said.Most Read from BloombergCuts to Section 8 Housing Assistance Loom Amid HUD UncertaintyThe Trump Administration Takes Aim at Transportation ResearchShelters Await Billions in Federal Money for Homelessness ProvidersNYC’s Congestion Pricing Pulls In $48.
For now, Moderna may be a good stock to put on a watch list, but it's likely too risky and volatile for the vast majority of ...
COVID-19 vaccines target emerging variants, offering improved protection. Learn about their effectiveness, timing, and safety ...
Norovirus infection rates are extremely high this year, raising the question: Why can’t a vaccine protect us from the stomach ...
scrippsnews on MSN1d
FDA cancels advisory committee's flu shot meeting amid uncertainty in HHS leadershipThe FDA has canceled an advisory committee's meeting on flu shot recommendations, raising concerns amid shifts in leadership ...
Investopedia on MSN7d
Moderna and Other Vaccine Stocks Climb Amid Concerns About Coronavirus Study in ChinaConcerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday.
A small study on Covid vaccine safety has sparked an online tempest — and highlighted the conundrum faced by some scientists.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback